Daclizumab Phase II Trial in Relapsing and Remitting Multiple SclerosisNeurol 69:785-789, Rose,J.W.,et al, 2007
Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple SclerosisNeurol 47:895-900, Anderson,O.,et al, 1996